Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
- PMID: 17267285
- DOI: 10.1016/j.it.2007.01.006
Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Abstract
The transcription factor PU.1 is an essential regulator of haemopoiesis and a suppressor of myeloid leukaemia. PU.1 displays a complex expression pattern characterized by high expression in myeloid cells and low amounts in lymphoid cells. Based on this transcriptional profile, and the analysis of cell lines and mice expressing altered levels of PU.1, a model has been proposed where the concentration of PU.1 determines cell fate, whereas the graded reduction, but not absence, of PU.1 facilitates leukaemogenesis. The recent reports of mouse strains that enable the accurate determination of PU.1 expression and the conditional inactivation of PU.1 in adult haemopoiesis have led us to re-examine our understanding of the complex functions of PU.1. Here, we will discuss the data that, we believe, argue against the dosage-sensitive model of PU.1-mediated lineage commitment and leukaemogenesis.
Similar articles
-
Visualizing PU.1 activity during hematopoiesis.Exp Hematol. 2005 Apr;33(4):395-402. doi: 10.1016/j.exphem.2004.12.010. Exp Hematol. 2005. PMID: 15781329
-
Role of PU.1 in hematopoiesis.Stem Cells. 1998;16(1):25-37. doi: 10.1002/stem.160025. Stem Cells. 1998. PMID: 9474745 Review.
-
PU.1: a crucial and versatile player in hematopoiesis and leukemia.Int J Biochem Cell Biol. 2008;40(1):22-7. doi: 10.1016/j.biocel.2007.01.026. Epub 2007 Feb 4. Int J Biochem Cell Biol. 2008. PMID: 17374502 Review.
-
Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.Int J Hematol. 2000 Feb;71(2):153-8. Int J Hematol. 2000. PMID: 10745625
-
PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.Exp Hematol. 2007 Mar;35(3):374-384. doi: 10.1016/j.exphem.2006.11.003. Exp Hematol. 2007. PMID: 17309818
Cited by
-
Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.Nat Commun. 2023 Dec 7;14(1):8102. doi: 10.1038/s41467-023-43697-y. Nat Commun. 2023. PMID: 38062031 Free PMC article.
-
Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia.Leukemia. 2016 Jan;30(1):14-23. doi: 10.1038/leu.2015.172. Epub 2015 Jul 1. Leukemia. 2016. PMID: 26126967 Free PMC article.
-
Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development.Immunity. 2016 Sep 20;45(3):527-539. doi: 10.1016/j.immuni.2016.07.012. Epub 2016 Aug 23. Immunity. 2016. PMID: 27566938 Free PMC article.
-
Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.Int J Hematol. 2012 Jul;96(1):65-73. doi: 10.1007/s12185-012-1106-x. Epub 2012 Jun 7. Int J Hematol. 2012. PMID: 22674382
-
The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells.Sci Rep. 2015 Jun 19;5:11410. doi: 10.1038/srep11410. Sci Rep. 2015. PMID: 26090649 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
